查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1429350

2024 年血液和血液成分全球市场报告

Blood And Blood Components Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

血液和血液成分市场规模预计在未来几年将显着成长。预计到 2028 年将以 5.2% 的复合年增长率 (CAGR) 增长至 506.7 亿美元。预测期内的预期成长将受到慢性疾病增加、政府措施以及全血需求增加等因素的推动。主要趋势包括强调协作努力、推出创新产品、优先考虑研发活动、使用基于物联网的产品来防止血液污染，以及注重有效的输血管理。我可以列出来。

由于创伤相关事件和道路事故的增加，血液和血液成分市场正在成长动力。严重的创伤，例如出血，通常会导致血液容量显着减少，而身体无法足够快地补充血液容量。同样，道路事故会导致大量失血，需要透过输血即时恢復。在这些情况下，需要将血液及其成分注射到患者体内。疾病发生率的增加、道路事故和创伤的激增增加了对血液的需求，从而推动了市场的成长。根据亚利桑那州卫生服务部的数据，与 2020 年相比，2021 年创伤相关死亡人数增加了 19%，其中跌倒是死亡和受伤的主要原因。

出血性疾病的迅速增加预计将进一步推动血液和血液成分市场的扩张。血友病等出血性疾病涉及凝血障碍，即使在轻伤或自发性受伤后也会导致过度或长时间出血。血液及其成分透过提供红血球、血小板和凝血因子等必需元素，在这些疾病的治疗中发挥至关重要的作用。输注这些成分来补充或替换患者体内缺失或功能失调的元素可以改善患者的凝血能力和整体健康。例如，根据美国疾病管制与预防中心 (CDC) 2023 年 7 月的数据，在美国，大约每5,000 名男性新生儿中就有1 人患有A 型血友病，每年估计有400 名婴儿出生时患有A 型血友病。此外，目前的估计表明，美国有 30,000 至 33,000 名男性患有血友病。因此，出血性疾病发生率的增加是推动血液和血液成分市场成长的关键驱动力。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球血液及血液成分市场驱动与限制因素
    • 市场驱动因素
    • 市场限制因素
  • 2018-2023 年全球血液和血液成分市场规模、表现和成长
  • 2023-2028年、2033年全球血液及血液成分市场规模及成长预测

第六章市场区隔

  • 全球血液和血液成分市场，按产品、性能和预测细分，2018-2023、2023-2028、2033
  • 全血
  • 血液成分
  • 全球血液和血液成分市场，按应用、性能和预测细分，2018-2023、2023-2028、2033
  • 贫血
  • 创伤与手术
  • 癌症治疗
  • 出血性疾病
  • 全球血液和血液成分市场，按最终用户细分，实际和预测，2018-2023、2023-2028、2033
  • 医院
  • 门诊手术中心
  • 其他的

第 7 章 区域与国家分析

  • 全球血液和血液成分市场，按地区、绩效和预测，2018-2023、2023-2028、2033
  • 全球血液和血液成分市场，按国家、实际和预测，2018-2023、2023-2028、2033

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争形势及公司概况

  • 血液及血液成分市场竞争形势
  • 血液和血液成分市场公司概况
    • American Red Cross
    • The Japanese Red Cross Society
    • Canadian Blood Services
    • Australian Red Cross
    • and Vitalant

第31章 其他大型创新公司

  • SANQUIN BLOOD SUPPLY FOUNDATION
  • New York Blood Center
  • Blood Bank of Alaska
  • Blood Centers of America
  • Xinjiang Deyuan Bioengineering
  • Harbin Pacific Biopharmaceutical
  • Southern Shuanglin Bio-Pharmacy
  • Beijing Tiantan Biological Products
  • Shanghai RAAS Blood Products
  • China Biologic Products
  • Hualan Biological Engineering
  • Biotest AG
  • Lorne Laboratories UK
  • LMB Germany
  • Bio Products Laboratory Ltd

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章 未来前景与潜力分析

第36章附录

简介目录
Product Code: r14362

Blood is defined as the entirety of human blood acquired from donors and processed for transfusion or further manufacturing. Blood components refer to therapeutic elements derived from human blood, encompassing red and white blood cells, platelets, and plasma. The market for blood and blood components involves the sale of these products, encompassing the collection of donor blood and its separation into necessary components for therapeutic purposes.

Key products in the blood and blood components market include whole blood and its various components. Whole blood, derived from standard blood donations, is employed in treating conditions such as excessive bleeding, exchange transfusions, and self-blood donation. Blood components, such as red blood cells, platelets, plasma, and white blood cells, find applications in treating anemia, trauma, surgery, cancer, and bleeding disorders. End-users in this market comprise hospitals, ambulatory surgical centers, and other healthcare facilities.

The blood and blood components market research report is one of a series of new reports from The Business Research Company that provides blood and blood components market statistics, including blood and blood components industry global market size, regional shares, competitors with a blood and blood components market share, detailed blood and blood components market segments, market trends and opportunities, and any further data you may need to thrive in the blood and blood components industry. This blood and blood components market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The blood and blood components market size has grown strongly in recent years. It will grow from $39.28 billion in 2023 to $41.29 billion in 2024 at a compound annual growth rate (CAGR) of 5.1%. The historical growth can be attributed to several factors, including a rise in the incidence of trauma and road accidents, a growing aging population, increased earnings and standards of living, elevated healthcare expenditure, and heightened awareness about blood donation.

The blood and blood components market size is expected to see strong growth in the next few years. It will grow to $50.67 billion in 2028 at a compound annual growth rate (CAGR) of 5.2%. Anticipated growth in the forecast period is driven by factors such as the rise in chronic diseases, government initiatives, and a growing demand for whole blood. Key trends include emphasis on collaborative efforts, introduction of innovative products, prioritizing research and development activities, utilization of IoT-based products to prevent blood contamination, and a focus on effective blood transfusion management.

The blood and blood components market is experiencing impetus due to an increase in trauma-related incidents and road accidents. Severe traumas, such as hemorrhages, often lead to a critical reduction in blood volume that the body cannot replenish swiftly enough. Similarly, road accidents result in substantial blood loss, necessitating immediate restoration through blood transfusions. These situations necessitate the infusion of blood and its components into the patient's body. The rising incidence of diseases and a surge in road accidents and traumas are elevating the demand for blood, thereby propelling market growth. According to the Arizona Department of Health Services, trauma-related deaths surged by 19% in 2021 compared to 2020, with falls being the leading cause of fatalities and injuries.

The burgeoning prevalence of bleeding disorders is anticipated to further drive the expansion of the blood and blood components market. Bleeding disorders, encompassing conditions such as hemophilia, involve impaired blood clotting, leading to excessive or prolonged bleeding, even from minor injuries or spontaneously. Blood and its components play a pivotal role in treating these disorders by providing essential elements such as red blood cells, platelets, and clotting factors. These components can be transfused to supplement or replace deficient or dysfunctional elements in patients, thereby enhancing their clotting abilities and overall health. For instance, as per the Centers for Disease Control and Prevention (CDC) in July 2023, hemophilia A occurs in approximately one in 5,000 male births in the United States, with an estimated 400 babies born with hemophilia A each year. Moreover, the current estimate suggests that between 30,000 to 33,000 males are living with hemophilia in the United States. Hence, the rising incidence of bleeding disorders is a key driver fueling the growth of the blood and blood components market.

The prevailing trend in the blood and blood components market revolves around an increasing number of collaborations among industry players. Companies are opting for partnerships and collaborations to broaden their market reach, expand their customer base, and raise awareness within the industry. For instance, the American Red Cross partnered with HealthStream to introduce a new program targeting healthcare organizations. Additionally, the BloodCenter of Wisconsin collaborated with SysLogic Inc. to explore RFID technology's potential in enhancing patient safety during the collection and transfusion of blood products.

Key companies within the blood and blood component market are prioritizing the development of innovative technologies, notably an advanced precision blood typing process, aimed at averting complications during blood transfusion procedures. Precision blood typing involves a proprietary process employing cutting-edge techniques and technologies to accurately determine an individual's specific blood type, encompassing both blood group and subgroup, ensuring safe and precise blood or blood product transfusions. For instance, in April 2023, the San Diego Blood Bank, a US-based blood bank, launched its precision blood initiative. This initiative seeks to elevate the standard of care for blood transfusion patients by scaling the precision blood typing process. The program's overarching goal is to positively impact and potentially save lives by enhancing the standard of care for individuals requiring blood transfusions.

In October 2022, Pfizer, a leading U.S. pharmaceutical company, successfully acquired Global Blood Therapeutics for an undisclosed sum. This strategic acquisition enhances Pfizer's expertise in addressing sickle cell disease, aligning with the company's 30-year legacy. Global Blood Therapeutics, a U.S.-based developer specializing in treatments for blood diseases, particularly sickle cell disease, brings valuable assets to further bolster Pfizer's position in the field.

Major companies operating in the blood and blood components market report are American Red Cross, The Japanese Red Cross Society, Canadian Blood Services, Australian Red Cross, and Vitalant, SANQUIN BLOOD SUPPLY FOUNDATION, New York Blood Center, Blood Bank of Alaska, Blood Centers of America, Xinjiang Deyuan Bioengineering, Harbin Pacific Biopharmaceutical, Southern Shuanglin Bio-Pharmacy, Beijing Tiantan Biological Products, Shanghai RAAS Blood Products, China Biologic Products, Hualan Biological Engineering, Biotest AG, Lorne Laboratories UK, LMB Germany, Bio Products Laboratory Ltd., Clinical Trials Laboratory Services (CTLS), Roche, Hemanext Inc., Kedrion Biopharma, KalVista Pharmaceuticals, Personal Genome, Cellphire, Inc., Immuno-Mycologics Inc., CSL Behring, Nordson Corporation, Octapharma Canada Inc., Abbott Laboratories, Grifols, Nipro Medical Corporation, Becton, Dickinson and Co

North America was the largest region in the blood and blood components market in 2023. Western Europe was the second largest region in the global blood and blood components market analysis. The regions covered in the blood and blood components market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the blood and blood components market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The blood and blood components market consist of sales of red cells, platelets, plasms, cryoprecipitated AHF, and granulocytes. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Blood And Blood Components Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on blood and blood components market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for blood and blood components? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The blood and blood components market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Product: Whole Blood; Blood Components
  • 2) By Blood Components: Red Blood Cells; Platelets; Plasma; White Blood Cells
  • 3) By End-User: Hospitals; Ambulatory Surgical Centers; Others
  • 4) By Application: Anemia; Trauma and Surgery; Cancer Treatment; Bleeding Disorders
  • Companies Mentioned: American Red Cross; The Japanese Red Cross Society; Canadian Blood Services; Australian Red Cross; and Vitalant
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Blood And Blood Components Market Characteristics

3. Blood And Blood Components Market Trends And Strategies

4. Blood And Blood Components Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Blood And Blood Components Market Size and Growth

  • 5.1. Global Blood And Blood Components Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Blood And Blood Components Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Blood And Blood Components Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Blood And Blood Components Market Segmentation

  • 6.1. Global Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Whole Blood
  • Blood Components
  • 6.2. Global Blood And Blood Components Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Anemia
  • Trauma & Surgery
  • Cancer Treatment
  • Bleeding Disorders
  • 6.3. Global Blood And Blood Components Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • Other End-Users

7. Blood And Blood Components Market Regional And Country Analysis

  • 7.1. Global Blood And Blood Components Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Blood And Blood Components Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Blood And Blood Components Market

  • 8.1. Asia-Pacific Blood And Blood Components Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Blood And Blood Components Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Blood And Blood Components Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Blood And Blood Components Market

  • 9.1. China Blood And Blood Components Market Overview
  • 9.2. China Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Blood And Blood Components Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Blood And Blood Components Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Blood And Blood Components Market

  • 10.1. India Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Blood And Blood Components Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Blood And Blood Components Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Blood And Blood Components Market

  • 11.1. Japan Blood And Blood Components Market Overview
  • 11.2. Japan Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Blood And Blood Components Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Blood And Blood Components Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Blood And Blood Components Market

  • 12.1. Australia Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Blood And Blood Components Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Blood And Blood Components Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Blood And Blood Components Market

  • 13.1. Indonesia Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Blood And Blood Components Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Blood And Blood Components Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Blood And Blood Components Market

  • 14.1. South Korea Blood And Blood Components Market Overview
  • 14.2. South Korea Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Blood And Blood Components Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Blood And Blood Components Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Blood And Blood Components Market

  • 15.1. Western Europe Blood And Blood Components Market Overview
  • 15.2. Western Europe Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Blood And Blood Components Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Blood And Blood Components Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Blood And Blood Components Market

  • 16.1. UK Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Blood And Blood Components Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Blood And Blood Components Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Blood And Blood Components Market

  • 17.1. Germany Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Blood And Blood Components Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Blood And Blood Components Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Blood And Blood Components Market

  • 18.1. France Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Blood And Blood Components Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Blood And Blood Components Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Blood And Blood Components Market

  • 19.1. Italy Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Blood And Blood Components Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Blood And Blood Components Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Blood And Blood Components Market

  • 20.1. Spain Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Blood And Blood Components Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Blood And Blood Components Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Blood And Blood Components Market

  • 21.1. Eastern Europe Blood And Blood Components Market Overview
  • 21.2. Eastern Europe Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Blood And Blood Components Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Blood And Blood Components Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Blood And Blood Components Market

  • 22.1. Russia Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Blood And Blood Components Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Blood And Blood Components Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Blood And Blood Components Market

  • 23.1. North America Blood And Blood Components Market Overview
  • 23.2. North America Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Blood And Blood Components Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Blood And Blood Components Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Blood And Blood Components Market

  • 24.1. USA Blood And Blood Components Market Overview
  • 24.2. USA Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Blood And Blood Components Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Blood And Blood Components Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Blood And Blood Components Market

  • 25.1. Canada Blood And Blood Components Market Overview
  • 25.2. Canada Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Blood And Blood Components Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Blood And Blood Components Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Blood And Blood Components Market

  • 26.1. South America Blood And Blood Components Market Overview
  • 26.2. South America Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Blood And Blood Components Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Blood And Blood Components Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Blood And Blood Components Market

  • 27.1. Brazil Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Blood And Blood Components Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Blood And Blood Components Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Blood And Blood Components Market

  • 28.1. Middle East Blood And Blood Components Market Overview
  • 28.2. Middle East Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Blood And Blood Components Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Blood And Blood Components Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Blood And Blood Components Market

  • 29.1. Africa Blood And Blood Components Market Overview
  • 29.2. Africa Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Blood And Blood Components Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Blood And Blood Components Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Blood And Blood Components Market Competitive Landscape And Company Profiles

  • 30.1. Blood And Blood Components Market Competitive Landscape
  • 30.2. Blood And Blood Components Market Company Profiles
    • 30.2.1. American Red Cross
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. The Japanese Red Cross Society
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Canadian Blood Services
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Australian Red Cross
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. and Vitalant
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Blood And Blood Components Market Other Major And Innovative Companies

  • 31.1. SANQUIN BLOOD SUPPLY FOUNDATION
  • 31.2. New York Blood Center
  • 31.3. Blood Bank of Alaska
  • 31.4. Blood Centers of America
  • 31.5. Xinjiang Deyuan Bioengineering
  • 31.6. Harbin Pacific Biopharmaceutical
  • 31.7. Southern Shuanglin Bio-Pharmacy
  • 31.8. Beijing Tiantan Biological Products
  • 31.9. Shanghai RAAS Blood Products
  • 31.10. China Biologic Products
  • 31.11. Hualan Biological Engineering
  • 31.12. Biotest AG
  • 31.13. Lorne Laboratories UK
  • 31.14. LMB Germany
  • 31.15. Bio Products Laboratory Ltd

32. Global Blood And Blood Components Market Competitive Benchmarking

33. Global Blood And Blood Components Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Blood And Blood Components Market

35. Blood And Blood Components Market Future Outlook and Potential Analysis

  • 35.1 Blood And Blood Components Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Blood And Blood Components Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Blood And Blood Components Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer